Showing 1 - 8 results of 8 for search 'Thoralf Lange', query time: 0.03s Refine Results
  1. 1
    JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse

    JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse by Thoralf Lange, Anja Edelmann, Udo Siebolts, Rainer Krahl, Claudia Nehring, Nadja Jäkel, Michael Cross, Jacqueline Maier, Dietger Niederwieser, Claudia Wickenhauser

    Published 2013-05-01
    Get full text
    Article
  2. 2
    The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia

    The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia by Thoralf Lange, Thomas Ernst, Franz X. Gruber, Jacqueline Maier, Michael Cross, Martin C. Müller, Dietger Niederwieser, Andreas Hochhaus, Markus Pfirrmann

    Published 2013-05-01
    Get full text
    Article
  3. 3
    A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib

    A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy... by Thomas Ernst, Franz X. Gruber, Oliver Pelz-Ackermann, Jacqueline Maier, Markus Pfirrmann, Martin C. Müller, Ingvild Mikkola, Kimmo Porkka, Dietger Niederwieser, Andreas Hochhaus, Thoralf Lange

    Published 2009-09-01
    Get full text
    Article
  4. 4
    Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia

    Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia by Madlen Jentzsch, Marius Bill, Juliane Grimm, Julia Schulz, Stefanie Beinicke, Janine Häntschel, Karoline Goldmann, Wolfram Pönisch, Georg-Nikolaus Franke, Vladan Vucinic, Michael Cross, Gerhard Behre, Thoralf Lange, Dietger Niederwieser, Sebastian Schwind

    Published 2019-02-01
    Get full text
    Article
  5. 5
    Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

    Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia by Ron Ram, Rainer Storb, Brenda M. Sandmaier, David G. Maloney, Ann Woolfrey, Mary E. D. Flowers, Michael B. Maris, Ginna G. Laport, Thomas R. Chauncey, Thoralf Lange, Amelia A. Langston, Barry Storer, George E. Georges

    Published 2011-08-01
    Get full text
    Article
  6. 6
    Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

    Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma by Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michael A. Pulsipher, Peter A. McSweeney, Leona Holmberg, Pamela S. Becker, Damian J. Green, Marco Mielcarek, David G. Maloney, Rainer Storb

    Published 2019-02-01
    Get full text
    Article
  7. 7
    A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

    A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation by Brian Kornblit, David G. Maloney, Barry E. Storer, Michael B. Maris, Lars Vindeløv, Parameswaran Hari, Amelia A. Langston, Michael A. Pulsipher, Wolfgang A. Bethge, Thomas R. Chauncey, Thoralf Lange, Finn B. Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, Rainer Storb, Brenda M. Sandmaier

    Published 2014-10-01
    Get full text
    Article
  8. 8
    S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.

    S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE... by Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela M Baerlocher, Jiri Mayer, Tim H Brümmendorf, Paul La Rosee, Dominik Heim, Stefan W Krause, Philipp Le Coutre, Christian Fabisch, Jenny Rinke, Thoralf Lange, Alice Fabarius, Marcel Lorch, Mathias Hänel, Frank Stegelmann, Georg-Nikolaus Franke, Markus Radsak, Volker Kunzmann, Danny Himsel, Denise Kohn, Thomas Lang, Rüdiger Hehlmann, Thomas Ernst, Markus Pfirrmann

    Published 2023-08-01
    Get full text
    Article

Search Tools: